Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Datesort ascending Article Title Journal

Omar Abdel-Rahman

 June 2018 Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial Clinical and Translational Oncology

Junjie Hang, Lixia Wu, Lina Zhu, Khigiang Sun, Ge Wang, Jingjing Pan, Suhua Zheng, Kequn Xu, Jiadi Du, Hua Jiang

 June 2018 Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study Cancer Medicine

Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan J. Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Tarek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group

 May 2018 Myocarditis Associated with Immune Checkpoint Inhibitors: an Expert Consensus on Data Gaps and a Call to Action The Oncologist

Patrick M. Cotogno, Lahiru K. Ranasinghe, Elisa M. Ledet, Brian E. Lewis, Oliver Sartor

 April 2018 Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer The Oncologist

Omar Abdel-Rahman, Winson Y. Cheung

 April 2018 Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study Medical Oncology

Omar Abdel-Rahman

 April 2018 Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials The Breast

Omar Abdel-Rahman

 February 2018 Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study Journal of Cancer Research and Clinical Oncology

Omar Abdel-Rahman, Winson Y. Cheung

 January 2018 External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study BJU International

Hitesh B. Mistry

 November 2017 On the relationship between tumour growth rate and survival in non-small cell lung cancer PeerJ

Detian Deng, Yu Du, Zhicheng Ji, Karthik Rao, Zhenke Wu, Yuxin Zhu, R. Yates Coley

 November 2017 Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach F1000 Research

Massimiliano Zanin

 November 2017 Using complex networks for refining survival prognosis in prostate cancer patient F1000 Research

Soren Wengel Mogensen, Anne H. Petersen, Ann-Sophie Buchardt, Niels Richard Hansen

 November 2017 Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients F1000 Research

Motoki Shiga

 November 2017 Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer F1000 Research

S. Peter Wu, Moses Tam, Raymond Mailhot Vega, Carmen A. Perez, Naamit Kurshan Gerber

 November 2017 Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up Radiation Oncology

Pages